Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 2
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2502CAPG, OCC-1, EED, RPLP0, RPLP0P2, AP1S2, RRAGD, PFDN4, CCDC104, C7orf28B, PSIP1, LPCAT1, FSCN3, RAB24, ZNF446, SEC11B, ZNF586, SCNM1, SF3A1, RUFY1, TRIM55, GOLGA4, GPATCH4, THOP1, TUBB2C, PHLDB3, FAM104A, FASTK, EIF2AK4, ZFP41, PRKRIP1, DSTN, PHIP, NUCKS1, TNRC8, CCDC132, EPRS, HIST1H4C, CDCA8,RNAsHumanUpregulated in HCV related HCC than HCV related non-HCC (With 3-fold change) DiagnosticHCV related HCC v/s HCV related non-HCC p < 0.01Tissue19821982
2585RPNI, ZNF161, EIF4G1, FNBP3, CCT6A, PPIB, IMPA2, GORASP2, KIAA0669, ATP2A2, PA200, ZNF91, GOLGA4, KIAA0494, SIAH1, UBQLN2, ADNP, TPD52L2, FDPS, DICER1RNAsHumanUpregulated in G2 than G1 (with fisher ratio more than 1.7) Prognostic G1 (well differentiated) HCV-HCC v/s G2 (moderately differentiated) HCV-HCC; associated with invasion or metastsis P < 0.005Tissue15710396

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top